How liquid biopsies, AI, and multi-cancer screening are transforming early diagnosis and patient outcomes

Dinesh Chauhan, CEO, CORE Diagnostics explains that the rising cancer burden, requires progressions critical for timely and accurate diagnosis, enabling better patient outcomes and improving survival rates
The post How liquid biopsies, AI, and multi-cancer screening are transforming early diagnosis and patient outcomes appeared first on Express Healthcare.